ArticleJournal of cardiovascular development and disease2024
Clinical Features and Patient Outcomes in Infective Endocarditis with Surgical Indication: A Single-Centre Experience.
Article in Journal of cardiovascular development and disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- The role of clinical frailty in predicting mortality following surgery for infective endocarditis.Turk gogus kalp damar cerrahisi dergisi · 2026Article
- Mitral Valve Repair for the Treatment of Acute Bacterial Endocarditis: Analysis of a 10-Year Single-Center Experience.Journal of clinical medicine · 2025Article
- Infective Endocarditis After TAVR-Surgical Challenges and Outcomes.Journal of clinical medicine · 2025Article
- Surgery inJournal of clinical medicine · 2025Article
- Surgery for Complex vs. Simple Native Left-Sided Endocarditis: Insights from an Extended Follow-Up on Survival, Recurrent Infection, and Valve Durability.Journal of clinical medicine · 2025Article
- Surgical and Clinical Aspects Associated with Double-Valve Infective Endocarditis.Journal of clinical medicine · 2025Article
- Infective Endocarditis During Pregnancy: Challenges and Future Directions.Journal of clinical medicine · 2025Review
- Reintervention for Acute Aortic Prosthesis Endocarditis: Early and Mid-Term Outcomes.Journal of clinical medicine · 2024Article
- Comparison of Sutureless and Sutured Aortic Valve Replacements in Patients with Redo Infective Endocarditis.Medicina (Kaunas, Lithuania) · 2024Article
- Breaking the Dogma of Intravenous Treatment for Infective Endocarditis: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2024Review
- The Impact of Neurological Complications in Endocarditis: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2024Review
- Native Valve Infective Endocarditis with Severe Regurgitation: What Matters Is Heart Failure.Journal of clinical medicine · 2024Article
- Body Weight's Role in Infective Endocarditis Surgery.Journal of cardiovascular development and disease · 2024Article
- Mechanical versus Biological Valve Prostheses for Infective Endocarditis Presenting with Stroke.Journal of clinical medicine · 2024Article
- The Surgical Outcome of Infective Endocarditis in South Africa over 10 Years: A Retrospective Review.Journal of clinical medicine · 2024Article
- The Usefulness of the CHAJournal of clinical medicine · 2024Article
- Exploring the Complexities of Non-Bacterial Thrombotic Endocarditis: Highlights from Literature and Case Studies.Journal of clinical medicine · 2024Review
- Complex Infective Endocarditis: Uncommon Presentations and Their Multisystem Complications - A Case Series.Journal of cardiovascular echographyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfective endocarditis (IE) is marked by a heightened risk of embolic events (EEs), uncontrolled infection, or heart failure (HF).
methodsPatients with IE and surgical indication were enrolled from October 2015 to December 2018. The primary endpoint consisted of a composite of major adverse events (MAEs) including all-cause death, hospitalizations, and IE relapses. The secondary endpoint was all-cause death.
resultsA total of 102 patients (66 ± 14 years) were enrolled: 50% with IE on prosthesis, 33% with IE-associated heart failure (IE-aHF), and 38.2% with EEs. IE-aHF and EEs were independently associated with MAEs (HR 1.9, 95% CI 1.1-3.4,
conclusionsIE-aHF and EEs were independently associated with MAEs. IE-aHF was also independently associated with the secondary endpoint.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.